Ulcerative colitis Trials in Kanazawa, Japan
Conditions / Ulcerative colitis / Kanazawa, Japan
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06052059 | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04033445 | A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT03996369 | Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT05507216 | ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 | COMPLETED | PHASE3 |
| NCT07184996 | An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis | RECRUITING | — |
| NCT06598943 | A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis | RECRUITING | PHASE2 |
| NCT04706793 | Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN) | COMPLETED | PHASE3 |
| NCT05061446 | Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE2 |
| NCT03950232 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | — |
| NCT05535946 | ABTECT - Maintenance | ACTIVE_NOT_RECRUITING | PHASE3 |